Zymeworks (ZYME) Change in Acquisitions & Divestments (2022 - 2026)
Zymeworks recorded quarterly Change in Acquisitions & Divestments of $70.2 million in Q1 2026, up 11.54% quarter-over-quarter from $62.9 million in Q4 2025, and up 50.75% year-over-year from $46.6 million in Q1 2025.
Zymeworks' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $70.2 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 50.75% year-over-year to $70.2 million; the TTM figure through Mar 2026 stood at $248.7 million (down 20.36% YoY), while the FY2025 annual figure was $225.1 million, down 30.87% from the prior year.
- Change in Acquisitions & Divestments came in at $70.2 million for Q1 2026 at Zymeworks, up from $62.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $125.9 million in Q3 2024 to a low of -$46.2 million in Q4 2022.
- A 5-year average of $64.5 million and a median of $62.3 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments soared 234.96% in 2023 and plunged 71.55% in 2025, its largest moves.
- Zymeworks' Change in Acquisitions & Divestments stood at -$46.2 million in 2022, then jumped by 234.96% to $62.3 million in 2023, then decreased by 23.11% to $47.9 million in 2024, then soared by 31.29% to $62.9 million in 2025, then gained by 11.54% to $70.2 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $70.2 million, $62.9 million, and $35.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.18 Mn |
| Mar 31, 2026 | 70.18 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Dec 31, 2025 | 62.92 Mn |
| Sep 30, 2025 | 35.83 Mn |
| Sep 30, 2025 | 35.83 Mn |
| Jun 30, 2025 | 79.78 Mn |
| Jun 30, 2025 | 79.78 Mn |
| Mar 31, 2025 | 46.55 Mn |
| Mar 31, 2025 | 46.55 Mn |
| Dec 31, 2024 | 47.92 Mn |
| Dec 31, 2024 | 47.92 Mn |
| Sep 30, 2024 | 125.95 Mn |
| Sep 30, 2024 | 125.95 Mn |
| Jun 30, 2024 | 91.85 Mn |
| Jun 30, 2024 | 91.85 Mn |
| Mar 31, 2024 | 59.85 Mn |
| Mar 31, 2024 | 59.85 Mn |
| Dec 31, 2023 | 62.33 Mn |
| Dec 31, 2023 | 62.33 Mn |
| Sep 30, 2023 | 119.20 Mn |
| Sep 30, 2023 | 119.20 Mn |
| Jun 30, 2023 | 124.33 Mn |
| Jun 30, 2023 | 124.33 Mn |
| Mar 31, 2023 | 44.22 Mn |
| Mar 31, 2023 | 44.22 Mn |
| Dec 31, 2022 | -46.18 Mn |
| Dec 31, 2022 | -46.18 Mn |
| Sep 30, 2022 | 43.14 Mn |
| Sep 30, 2022 | 43.14 Mn |